Synchronous endometrial and ovarian cancer and its recurrent risk factors: Case series

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 68, 394, 10.3322/caac.21492 Zaino, 2001, Simultaneously detected endometrial and ovarian carcinomas—A prospective clinicopathologic study of 74 cases: a gynecologic oncology group study, Gynecol. Oncol., 83, 355, 10.1006/gyno.2001.6400 Eifel, 1982, Simultaneous presentation of carcinoma involving the ovary and the uterine corpus, Cancer, 50, 163, 10.1002/1097-0142(19820701)50:1<163::AID-CNCR2820500131>3.0.CO;2-K Soliman, 2004, Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases, Gynecol. Oncol., 94, 456, 10.1016/j.ygyno.2004.05.006 Rodolakis, 2012, Clinicopathologic insight of simultaneously detected primary endometrial and ovarian carcinomas, Arch. Gynecol. Obstet., 285, 817, 10.1007/s00404-011-2046-z Yoneoka, 2019, Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma, J. Gynecol. Oncol., 30, 10.3802/jgo.2019.30.e7 Brinkmann, 2004, A molecular genetic and statistical approach for the diagnosis of dual-site cancers, J. Natl. Cancer Inst., 96, 1441, 10.1093/jnci/djh272 Anglesio, 2016, Synchronous endometrial and ovarian carcinomas: evidence of clonality, J. Natl. Cancer Inst., 108, djv428, 10.1093/jnci/djv428 Fujita, 1996, Application of clonal analysis: differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer, Am. J. Clin. Pathol., 105, 350, 10.1093/ajcp/105.3.350 Asa, 1999, Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament, Clin. Endocrinol. (Oxf), 51, 671, 10.1046/j.1365-2265.1999.00889.x Ulbright, 1985, Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases, Hum. Pathol., 16, 28, 10.1016/S0046-8177(85)80210-0 Jain, 2017, Clinicopathological characteristics and prognostic factors of synchronous endometrial and ovarian cancers—A single-institute review of 43 cases, Int. J. Gynecologic Cancer, 27, 10.1097/IGC.0000000000000971 Khalid, 2020, Synchronous primary endometrial and ovarian cancers: trends and outcomes of the rare disease at a South Asian tertiary care cancer center, Cureus, 12 Nofech-Mozes, 2008, Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma, Am. J. Clin. Pathol., 129, 912, 10.1309/CP3HGX7H753QQU8T Briët, 2005, Lymphvascular space involvement: an independent prognostic factor in endometrial cancer, Gynecol. Oncol., 96, 799, 10.1016/j.ygyno.2004.11.033 Chen, 2015, Prognostic significance of lymphovascular space invasion in epithelial ovarian cancer, J Cancer, 6, 412, 10.7150/jca.11242 Bese, 2016, Synchronous primary cancers of the endometrium and ovary with the same histopathologic type versus endometrial cancer with ovarian metastasis: a single institution review of 72 cases, Int. J. Gynecologic Cancer, 26, 10.1097/IGC.0000000000000600 Solmaz, 2016, Synchronous primary endometrial and ovarian cancers: a multicenter review of 63 cases, Tumori J., 102, 508, 10.5301/tj.5000378 Sebastianelli, 2010, Preoperative CA 125 tumour marker in endometrial cancer: correlation with advanced stage disease, J. Obstetrics and Gynaecol. Canada, 32, 856, 10.1016/S1701-2163(16)34657-6 Lo, 1997, Prognostic significance of tumour markers in endometrial cancer, Tumor Biol., 18, 241, 10.1159/000218037 Lin, 2020, Prognostic significance of elevated pretreatment serum levels of CEA and CA-125 in epithelial ovarian cancer, Cancer Biomarkers, 28, 285, 10.3233/CBM-201455 Matsuo, 2012, Significance of lymphovascular space invasion in epithelial ovarian cancer, Cancer Med., 1, 156, 10.1002/cam4.31 Heitz, 2014, Synchronous ovarian and endometrial cancer—An international multicenter case-control study, Int. J. Gynecologic Cancer, 24, 10.1097/IGC.0000000000000019